Juliya Fisher, MD
MOHS-Micrographic Surgery · Brooklyn, NYNPI 1609293760
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.1% of the total across 154 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by AbbVie at 27.0% of the total. Reporting peaked in 2020 at $852 and has fallen 71.2% since, to $246 in 2025.
Across 154 payments — averaging $27.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$499
- Merz North America, Inc.$438
- Amgen$416
- Galderma Laboratories, L.p.$321
- Sun Pharmaceutical Industries Inc.$207
- plus $1K from 19 others
What the payments were for
- Food & beverage$4,13398%
- Education$802%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 36 | $1,136 |
| Johnson & Johnson | 19 | $499 |
| Merz North America, Inc. | 4 | $438 |
| Amgen | 18 | $416 |
| Galderma Laboratories, L.p. | 8 | $321 |
| Sun Pharmaceutical Industries Inc. | 8 | $207 |
| Incyte Corporation | 7 | $145 |
| Lilly USA, LLC | 6 | $135 |
| Sanofi | 5 | $116 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $105 |
| VYNE Pharmaceuticals Inc. | 4 | $91 |
| LEO Pharma Inc. | 5 | $84 |
| E.r. Squibb & Sons, L.L.C. | 3 | $71 |
| Mayne Pharma Commercial LLC | 4 | $67 |
| Almirall LLC | 4 | $66 |
| Dermavant Sciences, Inc. | 3 | $64 |
| Nabriva Therapeutics, PLC | 2 | $45 |
| Bristol Myers Squibb | 2 | $43 |
| Strata Skin Sciences, Inc. | 3 | $36 |
| EPI Health, LLC | 2 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Dermira, Inc. | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Misonix Inc | 1 | $18 |
| Journey Medical Corporation | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AKLIEF$172
- SOOLANTRA$172
- EPIDUO FORTE$172
- BOTOX$157
- XEOMIN$147
How this compares
$4,213 in reported general payments places this provider in the 70th percentile of 75 mohs-micrographic surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 13 | $686 |
| Metronidazole | 11 | $566 |
| Ketoconazole | 11 | $113 |
| Triamcinolone Acetonide | 14 | $110 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Brooklyn
- Eyal LevitBrooklyn$22K
- Michael ShapiroBrooklyn$4K
- Sherry HsiungBrooklyn$2K
- Daniel SiegelSmithtown$450K
- Sherrif IbrahimVictor$412K
- Kavita MariwallaWest Islip$221K
- Ellen MarmurNew York$186K
- Kenneth MarkSouthampton$91K
- Michael TassavorNew York$55K
- Jane YooNew York$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.